(Q33824172)

29 July 2017

1 reference

title

HPA axis and cytokines dysregulation in schizophrenia: potential implications for the antipsychotic treatment (English)

1 reference

29 July 2017

0 references

3

1 reference

29 July 2017

Altamura AC

1

1 reference

29 July 2017

Boin F

series ordinal

2

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 December 1999

1 reference

European Neuropsychopharmacology

29 July 2017

published in

1 reference

29 July 2017

volume

10

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

1-4

1 reference

Depression dexamethasone nonsuppression and negative symptoms in schizophrenia

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900017-6

7 January 2021

A multidimensional (pharmacokinetic and clinical-biological) approach to neuroleptic response in schizophrenia. With particular reference to drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900017-6

7 January 2021

Hypothalamic-pituitary-adrenal axis in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900017-6

7 January 2021

Reduced Haloperidol/Haloperidol ratio and clinical outcome in schizophrenia: Preliminary evidences

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900017-6

7 January 2021

Dexamethasone suppression test in positive and negative schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900017-6

7 January 2021

Exposure to influenza epidemics during gestation and adult schizophrenia. A 40-year study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900017-6

7 January 2021

Season of birth: schizophrenia and bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900017-6

7 January 2021

A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900017-6

7 January 2021

Dexamethasone suppression test in depression and other psychiatric illness.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900017-6

7 January 2021

Hypothalamic-pituitary-adrenal axis hyperactivity and psychosis: recovery during an 8-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900017-6

7 January 2021

Olanzapine and fluperlapine mimic clozapine in preventing MK-801 neurotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900017-6

7 January 2021

Glycine agonists: what can they teach us about schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900017-6

7 January 2021

The dexamethasone suppression test in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900017-6

7 January 2021

Blunted cortisol response to a psychosocial stressor in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900017-6

7 January 2021

Influenza and schizophrenia in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900017-6

7 January 2021

Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900017-6

7 January 2021

The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900017-6

7 January 2021

Adult major affective disorder after prenatal exposure to an influenza epidemic.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900017-6

7 January 2021

Interleukin-2 and interleukin-6 in schizophrenia and mania: Effects of neuroleptics and mood stabilizers

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900017-6

7 January 2021

Lower plasma CC16, a natural anti-inflammatory protein, and increased plasma interleukin-1 receptor antagonist in schizophrenia: effects of antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900017-6

7 January 2021

Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: association with reduction in glucocorticoid receptor mRNA levels

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900017-6

7 January 2021

Prediction of response to haloperidol in schizophrenia: neuroendocrine, neuromorphological and clinical variables.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900017-6

7 January 2021

Influenza epidemics and incidence of schizophrenia, affective disorders and mental retardation in Western Australia: no evidence of a major effect.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900017-6

7 January 2021

Elevated circulating levels of IL-6 in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900017-6

7 January 2021

Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900017-6

7 January 2021

Symptomatology and cognitive impairment associate independently with post-dexamethasone cortisol concentrations in unmedicated schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900017-6

7 January 2021

Glutamate receptor dysfunction and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900017-6

7 January 2021

Association between central nervous system infections during childhood and adult onset schizophrenia and other psychoses: a 28-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900017-6

7 January 2021

Circadian rhythm of vital signs, norepinephrine, epinephrine, thyroid hormones, and cortisol in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900017-6

7 January 2021

Hypercortisolism associated with social subordinance or social isolation among wild baboons.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900017-6

7 January 2021

Prenatal exposure to influenza and schizophrenia in Surinamese and Dutch Antillean immigrants to The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900017-6

7 January 2021

Schizophrenia Following Pre-natal Exposure to Influenza Epidemics Between 1939 and 1960

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900017-6

7 January 2021

The effect of diagnosis and age on the DST: a metaanalytic approach

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900017-6

7 January 2021

No relation between risk of schizophrenia and prenatal exposure to influenza in Holland

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900017-6

7 January 2021

Relationship between in utero exposure to influenza epidemics and risk of schizophrenia in Denmark

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900017-6

7 January 2021

Dexamethasone suppression test in schizophrenia: Relationship to symptomatology, ventricular enlargement, and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900017-6

7 January 2021

The role of interleukin-6 in the activation of the hypothalamo-pituitary-adrenocortical axis and brain indoleamines by endotoxin and interleukin-1 beta.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900017-6

7 January 2021

The incidence of abnormal dexamethasone suppression in schizophrenia: a review and a meta-analytic comparison with the incidence in normal controls

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900017-6

7 January 2021

10.1016/S0924-977X(99)00017-6

Identifiers

DOI

1 reference

29 July 2017

1 reference